Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.2400
0.0000
(0.00%)
At close: February 26 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-23,125
-18,481
-5,392
Investing Cash Flow
--
132
-175
4,949
Financing Cash Flow
--
8,643
13,409
19,584
End Cash Position
--
27,650
41,970
47,195
Capital Expenditure
--
-42
-8
-20
Issuance of Capital Stock
--
218
91
--
Issuance of Debt
--
8,964
13,713
20,597
Repayment of Debt
--
-165
--
--
Repurchase of Capital Stock
--
--
--
-633
Free Cash Flow
--
-23,167
-18,489
-5,412
12/31/2020 - 2/22/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
430.BE Terns Pharmaceuticals Inc
3.6000
+1.12%
ANL Adlai Nortye Ltd.
2.2203
+0.92%
TRDA Entrada Therapeutics, Inc.
12.02
-0.83%
CGEM Cullinan Therapeutics, Inc.
8.45
-1.29%
IMCR Immunocore Holdings plc
30.77
+5.34%
IMTX Immatics N.V.
4.2500
-2.97%
MNPR Monopar Therapeutics Inc.
31.29
+0.58%
PTGX Protagonist Therapeutics, Inc.
36.15
+3.02%
AGIO Agios Pharmaceuticals, Inc.
34.44
-2.13%
VNDA Vanda Pharmaceuticals Inc.
4.7100
+5.61%